![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 8194-8201, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Subunit from the Hyperthermophile
Thermotoga maritima
From the Universität zu Köln, Institut für Biochemie, Otto-Fischer-Str. 12-14, D-50674 Köln, Germany
Received for publication, December 4, 2001, and in revised form, December 20, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Tryptophan synthase catalyzes the last two
steps in the biosynthesis of the amino acid tryptophan. The enzyme is
an Hyperthermophilic microorganisms grow optimally close to the
boiling point of water (1). It is interesting to identify those
molecular adaptations that allow proper function of metabolism under
these extreme conditions (2). In particular, enzymes from
hyperthermophiles must be extremely thermostable, and labile metabolites must be protected from spontaneous degradation (3-5).
The pathway of tryptophan biosynthesis from chorismate comprises seven
catalytic functions (6). In most organisms, the trp genes
are organized in operons, which guarantees their coordinated expression
in response to the amount of tryptophan available in the growth medium
(7). The order of the trp operon from the hyperthermophile
Thermotoga maritima trpE(GD)CFBA (8) resembles the
organization of the trp operon from Escherichia
coli (9). The last four steps of tryptophan biosynthesis are
catalyzed by phosphoribosyl anthranilate isomerase
(TrpF),1 indoleglycerol
phosphate synthase (TrpC), and the Less is known about the specific structural and functional adaptations
of the tryptophan synthase from T. maritima, which catalyzes
the conversion of indoleglycerol phosphate (IGP) and serine to
tryptophan (16). The tryptophan synthases characterized so far consist
of two TrpA (


complex in mesophilic microorganisms. The
-subunit
(TrpA) catalyzes the cleavage of indoleglycerol phosphate to
glyceraldehyde 3-phosphate and indole, which is channeled to the active
site of the associated
-subunit (TrpB1), where it reacts with serine
to yield tryptophan. The TrpA and TrpB1 proteins are encoded by the
adjacent trpA and trpB1 genes in the
trp operon. The genomes of many hyperthermophilic microorganisms, however, contain an additional trpB2 gene
located outside of the trp operon. To reveal the properties
and potential physiological role of TrpB2, the trpA,
trpB1, and trpB2 genes of Thermotoga
maritima were expressed heterologously in Escherichia coli, and the resulting proteins were purified and characterized. TrpA and TrpB1 form the familiar 


complex, in which the two different subunits strongly activate each other. In contrast, TrpB2
forms a
2-homodimer that has a high catalytic efficiency kcat/K

![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- and
-subunits of tryptophan
synthase (TrpA and TrpB1, respectively). It was shown that TrpF and
TrpC from T. maritima are far more thermostable than their
homologs from mesophiles (10, 11), probably because of an increased
association state in the case of TrpF (12, 13) and an increased number
of salt bridges in the case of TrpC (11, 14). Moreover, both TrpF and
TrpC from T. maritima are catalytically more active at
80 °C than the orthologous enzymes from E. coli at
37 °C, thus outrunning the unproductive hydrolysis of their thermolabile substrates under physiological conditions (10, 11,
15).
) and two TrpB1 (
) structural entities, which are
organized either as four monofunctional subunits or as two bifunctional

-subunits (17). The x-ray structure at 2.8 Å resolution of the
tryptophan synthase from Salmonella typhimurium revealed an



quaternary structure (18). The structure of isolated TrpA
from Pyrococcus furiosus confirmed that this enzyme has a
(
)8-barrel fold (19), which is the most frequently
encountered topology among single domain proteins and is also adopted
by TrpF and TrpC (20, 21). TrpB1 consists of two domains, which both comprise a central open
-sheet that is surrounded by
-helices (18). TrpA catalyzes the aldolytic cleavage of IGP to glyceraldehyde 3-phosphate (GA3P) and indole, which condenses with serine at the
active site of TrpB1 to yield tryptophan (Fig.
1). The hydrophobic intermediate indole
passes directly from the
-site to the
-site via a long tunnel,
which prevents its loss from the cell by diffusion across the
cytoplasmic membrane (22, 23). There is pronounced allosteric
communication between the TrpA and TrpB1 subunits from E. coli, which is reflected in a mutual activation of their catalytic activities which keeps the two reactions in phase and prevents accumulation of indole (24). It appears that the 


complex is in an equilibrium between a low activity "open" and a high activity "closed" state, which is shifted by allosteric ligands and
monovalent cations (25). The basis of the corresponding conformational
transitions has been characterized by x-ray structure analysis of a
number of enzyme-ligand complexes (26-30).

View larger version (14K):
[in a new window]
Fig. 1.
Reactions catalyzed by the
[TrpA·TrpB]2 complex and its TrpA and TrpB
subunits.
Recently, the genome sequencing of T. maritima (31)
and of other hyperthermophiles has identified a trpB2 gene
outside of the trp operon. To reveal the roles in tryptophan
biosynthesis of the two different TrpB variants,
tmtrpA, tmtrpB1, and tmtrpB2 from
T. maritima were expressed heterologously in E. coli, and the corresponding protein products were purified and
characterized by hydrodynamic measurements and steady-state enzyme
kinetics. The results show that tmTrpB1 associates with tmTrpA to an



complex, in which the two different subunits strongly
activate each other. tmTrpB2, which does not bind to tmTrpA but is
catalytically highly active, has an extremely low
Km value for indole. It appears that tmTrpB1 has
the same role in tryptophan biosynthesis as the known TrpB1 enzymes
from mesophiles, whereas tmTrpB2 acts as a salvage protein that
prevents the loss of indole at the physiological growth temperatures of hyperthermophiles.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
DNA Manipulation and Sequence Analysis-- Preparation of DNA, amplification, extraction, digestion with restriction endonucleases, ligation, and sequencing were performed as described (32).
Subcloning of tmtrpA, tmtrpB1, and tmtrpB2 Genes from T. maritima-- The genes tmtrpA and tmtrpB1 were amplified by PCR using the plasmid pDStmtrpAB (16) as template. For amplification of tmtrpA, the oligonucleotides 5'-GGTTCATATGAAGGGCTTTATTGCATACATC-3' with a NdeI site (in boldface type) and 5'-CGATGAATTCTCATTTTCCGAGGAGTTCTTTT-3' with an EcoRI site (in boldface type) were used as 5'- and 3'-primers, respectively. The tmtrpB1 gene was amplified with the primers 5'-GGATCATATGAAAGGTTACTTCGGTCCTTA-3' and 5'-CCGTGAATTCTCATCTTATCCTCTCCCTGACGTA-3', again introducing NdeI and EcoRI sites (in boldface type). Using the two newly introduced restriction sites, the amplified DNA fragments were cloned into different pET vectors (Stratagene), yielding the plasmids pET21a-tmtrpA and pET24a-tmtrpB1. The gene tmtrpB2 was amplified by PCR using genomic DNA of T. maritima as the template. The primers 5'-ACCGCATATGAGAATTGTTGTGAA-3' and 5'-CAGGAATTCAAGCTTTCACACGTACGCTGT-3' were used, introducing NdeI and HindIII sites, respectively (in boldface type). The amplified DNA fragment was cloned into the vector pET21a to yield the plasmid pET21a-tmtrpB2. All inserts were sequenced entirely to exclude inadvertent PCR mutations.
Production of tmTrpA, tmTrpB1, tmTrpB2, the
[tmTrpA·tmTrpB1]2 Complex, and of
Glyceraldehyde-3-phosphate Dehydrogenase from T. maritima(tmGAPDH)--
Heterologous expression of tmtrpA was
conducted in E. coli BL21(DE3) cells containing the plasmid
pET21a-tmtrpA. For reasons unknown so far, tmtrpA
(and tmtrpB1 and tmtrpB2) are being expressed in
the absence of
isopropyl-1-thio-
-D-galactopyranoside. Therefore, the cells were grown overnight at 37 °C in 1 liter of LB medium supplemented with 150 µg/ml ampicillin but without the addition of
isopropyl-1-thio-
-D-galactopyranoside. The cell pellet
resulting from centrifugation was resuspended in 10 mM
potassium phosphate buffer at pH 7.5 and lysed by sonification (Branson
Sonifier W-250, 3 × 3 min, 50% pulse, 0 °C). According to
SDS-PAGE, 90% of tmTrpA was found in the soluble fraction of the cell
extract. 100 units of benzonase (Merck) was added to this fraction,
which was then incubated for 1 h at 37 °C to degrade nucleic
acids and subsequently for 20 min at 75 °C to denature the
benzonase. The resulting suspension was centrifuged (Sorvall SS34,
13,000 rpm, 30 min, 4 °C), and the pellet, which contained
heat-labile host proteins, was discarded. The supernatant was loaded on
an anion exchange column (Mono Q, 2 × 11 cm, Amersham
Biosciences, Inc.) that was equilibrated with 10 mM
potassium phosphate buffer, pH 7.5, at room temperature. The column was
washed with 4 column volumes of equilibration buffer, and bound
proteins were eluted with a linear gradient of 0-750 mM
potassium chloride at pH 7.5. tmTrpA eluted at 150-200 mM
potassium chloride, as judged from SDS-PAGE and conductivity
measurements. Sufficiently pure fractions were pooled, concentrated
using Centricon-10 devices (Millipore), and dialyzed against 10 mM potassium phosphate buffer, pH 7.5, containing 50 mM potassium chloride. The protein was shock frozen in
liquid nitrogen at a concentration of 10 mg/ml. The purification
yielded 50 mg of tmTrpA out of 1 liter of cell culture with a purity of
about 99% as judged by SDS-PAGE.
For expression of tmtrpB1 and tmtrpB2, E. coli BL21(DE3) cells containing the plasmids pET24a-tmtrpB1 and pET21a-tmtrpB2 were used. Cells were grown as described for tmtrpA, with the exceptions that kanamycin instead of ampicillin was added for maintenance of pET24a-tmtrpB1 and 20 °C instead of 37 °C was used, which increased the fraction of soluble protein to about 40% for tmTrpB1 and about 10% for tmTrpB2 (33). Harvesting of cells, cell lysis, incubation with benzonase, heat precipitation of host proteins, and anion exchange chromatography were performed as described for tmTrpA, with the exception that the buffer solutions were supplemented with 40 µM pyridoxal 5'-phosphate (PLP). Both tmTrpB proteins eluted from the Mono Q column at about 150-200 mM potassium chloride. Fractions containing either tmTrpB protein were pooled, concentrated using Centricon-10 devices, and loaded on a gel filtration column (Superdex 75, Hiload 26/60, Amersham Biosciences, Inc.) equilibrated with 50 mM potassium phosphate at pH 7.5, containing 300 mM potassium chloride and 40 µM PLP. The tmTrpB proteins, which eluted with a purity above 95% as judged from SDS-PAGE, were shock frozen in liquid nitrogen at concentrations of 4 mg/ml (tmTrpB1) and 1.5 mg/ml (tmTrpB2). From 1 liter of cell culture, 16 mg of tmTrpB1 and 6 mg of tmTrpB2 were obtained.
The tmgapdh gene cloned into the plasmid pKM1 was expressed
using E. coli BL21(DE3) cells (34). The cells were grown at 37 °C in 1 liter of LB medium supplemented with 150 µg/ml
ampicillin, inducted with 1 mM
isopropyl-1-thio-
-D-galactopyranoside at
A600 = 0.6, and incubated overnight.
Harvesting of cells, cell lysis, and incubation with benzonase were
performed in a way similar to that described for tmTrpA, but a 50 mM EPPS buffer at pH 7.5 was used instead of 10 mM potassium phosphate. After heat precipitation of host
proteins at 75 °C for 30 min, tmGAPDH was pure to 90%. The protein
was dialyzed against 10 mM EPPS buffer at pH 7.5, containing 10 mM potassium chloride, concentrated to 5.2 mg/ml using Centricon-10 devices, and shock frozen in liquid nitrogen. From 1 liter of cell culture, 14 mg of tmGAPDH was obtained.
Analytical Methods--
Purification of proteins was followed by
electrophoresis on 12.5% SDS-polyacrylamide gels using the system of
Laemmli (35) and staining with Coomassie Blue. The
concentration of tmTrpA was determined using the molar extinction
coefficient
280 = 18.9 mM
1
cm
1, which was calculated from the amino acid sequence
(36). The concentrations of tmTrpB1 and tmTrpB2 were determined
according to Bradford (37) because the strong absorption at 280 nm of the bound cofactor PLP impeded a reliable calculation of
280 from the amino acid sequences.
Analytical gel filtration was performed at a flow rate of 0.5 ml/min on a Superdex 75 column (1 × 30 cm) that was equilibrated with 50 mM potassium phosphate buffer at pH 7.5 at 25 °C containing 300 mM potassium chloride. Apparent molecular masses were calculated from the corresponding elution volumes, using a calibration curve that was obtained with standard proteins. Sedimentation velocity and sedimentation equilibrium runs were performed at 20 °C in a Beckman analytical ultracentrifuge (model Optima XLA), monitoring the absorption at 277 nm. The velocity runs were performed at 54,000 (tmTrpA) or 52,000 rpm (other proteins) and the equilibrium runs at 22,000 rpm (tmTrpA) or 8,000 rpm (other proteins). The proteins were dissolved in 100 mM potassium phosphate at pH 7.5, containing 180 mM potassium chloride and 40 µM PLP. For analysis of the equilibrium runs, a floating base-line computer program that adjusts the baseline absorbance (A) was used to obtain the best linear fit of lnA versus the square of the radial distance (r2). Molecular masses were calculated assuming a partial specific volume of 0.73 ml/g.
Steady-state Enzyme Kinetics--
The cleavage of IGP to
GA3P and indole (A-reaction; Fig. 1) was measured under steady-state
conditions between 30 and 60 °C in a coupled enzymatic assay (38).
In this assay, arsenate and GA3P produced by tmTrpA were converted by
tmGAPDH into 1-arseno-3-phosphoglycerate upon reduction of
NAD+ to NADH. The reaction is irreversible because of the
spontaneous hydrolysis of 1-arseno-3-phosphoglycerate into arsenate and
3-phosphoglycerate. Initial velocities were measured by absorption
spectroscopy and analyzed using 
340 (NADH
NAD+) = 6.22 mM
1
cm
1. Initial velocities were measured, and
Vmax and
K

290 (Trp
indole) = 1.89 mM
1 cm
1 (40). Initial
velocities were measured as a function of the concentration of either
indole or serine, with the other substrate being present at saturating
concentrations. In the case of tmTrpB2, entire progress curves at
saturating concentrations of serine were analyzed with the integrated
form of the Michaelis-Menten equation (41), which allowed determination
of the upper limit of
K

290 (Trp
IGP) = 0.56 mM
1 cm
1 (42). Alternatively,
the AB-reaction was followed in a coupled reaction, which is similar to
that used to follow the A-reaction (43). Initial velocities were
measured as a function of the concentration of either IGP or serine,
with the other substrate being present at saturating concentrations.
The kcat and Km values of
the A- and the AB-reactions determined between 30 and 60 °C were
extrapolated to 80 °C by an Arrhenius plot.
| |
RESULTS |
|---|
|
|
|---|
The Genomes of Many Hyperthermophiles Contain Two Different trpB Genes
The genes trpA and trpB1 of the
hyperthermophilic bacterium T. maritima are adjacent in the
trp operon (8). The sequencing of the whole genome of
T. maritima (31) identified a gene outside of the
trp operon, which has significant sequence similarity to trpB1 and was designated trpB2. It is likely that
the trpB2 gene is expressed in T. maritima
because the upstream region on the genome contains consensus sequences
that are typical of bacterial promoters and ribosome binding sites
(data not shown). A data base search revealed that trpB2
genes are also present in the genomes of most of the other investigated
hyperthermophilic Bacteria and Archaea but are generally absent from
the genomes of mesophiles. A phylogenetic tree based on amino acid
sequence comparisons shows that TrpB1 and TrpB2 proteins form two
separate groups (Fig. 2). Within the two
groups, proteins display sequence identities of about 60%, whereas
between members from different groups the identities are only about
30%. Most hyperthermophiles contain one TrpB1 and one TrpB2 protein;
others, for example Sulfolobus solfataricus, possess two
different TrpB2 variants but lack TrpB1.
Fig. 3a presents the amino
acid sequence alignment of the two TrpB variants from T. maritima, tmTrpB1 and tmTrpB2, which show an overall identity of
38%. It is evident that those amino acids, which are conserved both in
the TrpB1 and TrpB2 sequences, cluster at the putative active sites. In
contrast, amino acids that are conserved in only one of the two TrpB
groups are distributed along the sequences. The major differences
between the two proteins are a long N-terminal extension and two
shorter insertions in tmTrpB2, which are located in regions where
tmTrpB1 interacts with tmTrpA, as deduced from the structure of
S. typhimurium tryptophan synthase (Fig. 3b).
|
|
Production and Purification of tmTrpA, tmTrpB1, and tmTrpB2
The tmtrpA, tmtrpB1, and tmtrpB2 genes were cloned into different pET vectors and expressed heterologously in E. coli BL21(DE3) cells (44). tmTrpA could be produced in soluble form at 37 °C, but tmtrpB1 and tmtrpB2 had to be expressed at 20 °C to suppress in part the formation of insoluble aggregates (33). The resulting thermostable tmTrpA, tmTrpB1, and tmTrpB2 proteins were purified from the soluble fraction of the cell extract, using a heat step to remove thermolabile host proteins followed by ion exchange chromatography. The three proteins were more than 95% pure, as judged from SDS-PAGE (data not shown). The [tmTrpA·tmTrpB1]2 complex was produced by mixing tmTrpA and tmTrpB1 (see below).
Association States and Complex formation of tmTrpA, tmTrpB1, and tmTrpB2
Analytical gel filtration on a calibrated Superdex 75 HR column
was used to test whether tmTrpB1 and tmTrpB2 form a complex with tmTrpA
at 25 °C. The results are summarized in Fig.
4. Separately, tmTrpA, tmTrpB1, and
tmTrpB2 elute as well defined peaks. When tmTrpB1 is mixed with a molar
excess of tmTrpA, the tmTrpB1 peak is replaced by a new and faster
elution peak, which represents a complex of tmTrpA and tmTrpB1 (Fig.
4a). In contrast, the elution profile of a mixture of tmTrpA
and tmTrpB2 excludes any significant complex formation between these
proteins (Fig. 4b). The elution time of separated tmTrpA
corresponds to a molecular mass of 26.8 kDa, comparing well with the
calculated molecular mass for the monomer (26.7 kDa). The elution times
of tmTrpB1 and tmTrpB2, however, correspond to molecular masses of 49.4 and 61.7 kDa, respectively, which are between the calculated molecular
masses for the respective monomers (42.9 and 46.4 kDa) and homodimers (85.8 and 92.8 kDa). Analytical ultracentrifugation was therefore performed to clarify the association states of tmTrpB1 and tmTrpB2 and
to assess the stoichiometry of the complex between tmTrpA and tmTrpB1
(Table I). Sedimentation velocity runs
showed that the separated proteins are homogeneous species, yielding
s20,w values of 2.8 for tmTrpA and
5.4 for both tmTrpB1 and tmTrpB2. The analysis of sedimentation
equilibrium runs confirms that separated tmTrpA exists mainly as an
-monomer and shows that both tmTrpB1 and tmTrpB2 are
2-dimers. Runs that were performed with a mixture of
tmTrpA and tmTrpB1 show that they form an 


complex, as observed for other investigated tryptophan synthases (6, 45). In
accordance with analytical gel filtration, analytical
ultracentrifugation detected no complex formation between tmTrpA and
tmTrpB2.
|
|
Heat Stabilities
To test their stability against irreversible inactivation by heat,
tmTrpA, tmTrpB1, tmTrpB2, and the 


complex of tmTrpA with
tmTrpB1 were incubated at 85 °C. Samples withdrawn after different
time intervals were chilled on ice, and their residual catalytic
activities were measured at 60 °C. For all proteins, a
time-dependent monoexponential decay of the catalytic
activity was observed. The measured half-lives were 125 min for tmTrpA, 320 min for both tmTrpB1 and tmTrpB2, and 400 min for the 


complex. These results suggest that all proteins are very thermostable and that complex formation further stabilizes both tmTrpA and tmTrpB1.
Steady-state Enzyme Kinetics
The catalytic activities at 80 °C of separated tmTrpA
(A-reaction), separated tmTrpB1 and tmTrpB2 (B-reaction), and of the 


complex of tmTrpA and tmTrpB1 (A-reaction, B-reaction, and AB-reaction, Fig. 1) were determined under steady-state conditions.
A-reaction--
Table II
shows that the catalytic efficiency
kcat/K

|
Analytical gel filtration and analytical ultracentrifugation performed at room temperature suggest that tmTrpA and tmTrpB2 do not form a complex (Fig. 4b and Table I). To test whether such a complex might be formed at higher temperatures, the catalytic activity of tmTrpA was measured at 60 °C in the presence and absence of an equimolar concentration of tmTrpB2. Because the presence of tmTrpB2 did not affect the tmTrpA activity, the formation of a functional complex between tmTrpA and tmTrpB2 can be excluded both at 25 and at 60 °C.
B-reaction--
The B-activities of separated
tmTrpB1(
2) and of tmTrpB1 in the
[tmTrpA·tmTrpB1]2 complex are compared in Table
III, which shows that tmTrpB1 is
activated by tmTrpA. Whereas kcat and
K


- and the
-subunits in the 


complex is comparably strong in the enzymes from T. maritima and E. coli. This finding supports the concept of "corresponding
states," which postulates that mesophilic and hyperthermophilic
enzymes are comparably flexible, stable, and active at their respective
physiological temperatures (3, 46-48).
|
Activity measurements with tmTrpB2 (
2) showed the
absence of significant activation by tmTrpA, as expected (data not
shown). The
kcat/K



|
AB-reaction--
In the AB-reaction (Fig. 1), the 


complex catalyzes the conversion of IGP and serine to tryptophan. Table
V summarizes the steady-state enzyme
kinetic constants kcat,
K





|
| |
DISCUSSION |
|---|
|
|
|---|
The phylogenetic tree depicted in Fig. 2 shows that TrpB1 and TrpB2 proteins form two separate groups, which presumably evolved independently from each other after an early gene duplication event. In separated form both tmTrpB1 and tmTrpB2 are homodimers (Table I) and have similar amino acid sequences at their putative active sites containing all residues that are catalytically essential for the TrpB reaction (Fig. 3a and Ref. 17). In accordance with these observations, both tmTrpB variants catalyze the B-reaction with high efficiency at 80 °C (Table IV). Moreover, the tmtrpB1 gene is part of the trp operon of T. maritima (8), and the upstream sequence of the tmtrpB2 gene contains a putative promoter and a ribosome binding site (31). It therefore has to be assumed that both tmTrpB1 and tmTrpB2 are produced in T. maritima and play a functional role in tryptophan biosynthesis.
The most significant difference between the two tmTrpB proteins is that tmTrpA forms a functional complex only with tmTrpB1 (Tables I-III and Fig. 4). Sequence alignment shows that tmTrpB2 contains additional amino acids compared with tmTrpB1 (Fig. 3a), which are inserted at sites where TrpA and TrpB interact with each other (Fig. 3b). It appears therefore that the binding of tmTrpA to tmTrpB2 is prevented by sterical hindrance caused by these insertions. Remarkably, maize contains two enzymes of secondary metabolism which show significant sequence similarities to TrpA and catalyze the production of indole from IGP efficiently in the absence of TrpB (49). Sequence deviations of these TrpA homologs have been identified in the intermolecular interaction domain, which might prevent their complex formation with TrpB.
Whereas tmTrpB1 is likely to receive indole from tmTrpA by
intermolecular channeing (22, 23), the cellular source of indole to be
used by tmTrpB2 is not evident. In E. coli, the cleavage of
tryptophan as the sole carbon source to pyruvate and indole is the main
source for indole (50). This reaction is catalyzed by the enzyme
tryptophanase, but no gene with significant sequence similarity to
known tryptophanase genes appears to be present on the genome of
T. maritima (31). Alternatively, at 80 °C IGP might be
spontaneously degraded with a significant rate into GA3P and indole,
which could then be used by tmTrpB2 for tryptophan biosynthesis.
However, at 80 °C no conversion of IGP into tryptophan could be
detected in the presence of tmTrpB2 (or tmTrpB1) and serine (data not
shown). It has been shown for the E. coli tryptophan synthase that less than 1% of the indole produced by ecTrpA is released into the solvent at 25 °C instead of being channeled to
ecTrpB1 (51, 52). It is possible, however, that a larger fraction of
indole leaks from the channel connecting tmTrpA with tmTrpB1 at the
high physiological temperature of T. maritima. Consistent
with this hypothesis, tmTrpB2, because of its extremely low
K



tryptophan synthase
complex with TrpA. In mesophilic organisms the trpB2 gene
might have been lost in the course of evolution because of the lack of
selective pressure, provided that life began in boiling water (53).
|
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ariel Lustig for running the analytical ultracentrifuge, Steffi Hentzelt and Halina Szadkowski for the expression plasmids and [tmTrpA·tmTrpB1]2 protein, Dr. Wolfgang Liebl for the T. maritima DNA, Simona Cerrone for purification of tmGAPDH, and Catharina Jürgens and Birte Höcker for a critical reading of the manuscript. We appreciate discussions with Drs. Charles Yanofsky and Kasper Kirschner on the physiological role of tmTrpB2.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
49-221-470-6432; Fax: 49-221-470-6731; E-mail:
Reinhard.Sterner@Uni-Koeln.de.
Published, JBC Papers in Press, December 26, 2001, DOI 10.1074/jbc.M111541200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TrpF, phosphoribosyl
anthranilate isomerase;
TrpC, indoleglycerol phosphate synthase;
TrpA, TrpB,
- and
-subunits of tryptophan synthase, respectively;
ec, E. coli;
EPPS, 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid;
GA3P, glyceraldehyde 3-phosphate;
GAPDH, glyceraldehyde-3-phosphate
dehydrogenase;
IGP, indoleglycerol phosphate;
IND, indole;
PLP, pyridoxal 5'-phosphate;
tm, T. maritima.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Stetter, K. O. (1999) FEBS Lett. 452, 22-25[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Daniel, R. M., and Cowan, D. A. (2000) Cell. Mol. Life Sci. 57, 250-264[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Jaenicke, R., and Böhm, G. (1998) Curr. Opin. Struct. Biol. 8, 738-748[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Sterner, R., and Liebl, W. (2001) Crit. Rev. Biochem. Mol. Biol. 36, 39-106[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Vieille, C.,
and Zeikus, G. J.
(2001)
Microbiol. Mol. Biol. Rev.
65,
1-43 |
| 6. | Yanofsky, C., Miles, E., Bauerle, R., and Kirschner, K. (1999) in The Encyclopedia of Molecular Biology (Creighton, T. E., ed), Vol. 4 , pp. 2276-2689, John Wiley & Sons, Inc., New York |
| 7. | Yanofsky, C. (2001) Annu. Rev. Biochem. 70, 1-37[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Sterner, R., Dahm, A., Darimont, B., Ivens, A., Liebl, W., and Kirschner, K. (1995) EMBO J. 14, 395-4404 |
| 9. |
Yanofsky, C.,
Platt, T.,
Crawford, I. P.,
Nichols, B. P.,
Christie, G. E.,
Horowitz, H.,
VanCleeput, M.,
and Wu, A. M.
(1981)
Nucleic Acids Res.
9,
6647-6668 |
| 10. | Sterner, R., Kleeman, G. R., Szadkowski, H., Lustig, A., Hennig, M., and Kirschner, K. (1996) Protein Sci. 5, 2000-2008[Abstract] |
| 11. | Merz, A., Knöchel, T., Jansonius, J. N., and Kirschner, K. (1999) J. Mol. Biol. 288, 753-763[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Hennig, M., Sterner, R., Kirschner, K., and Jansonius, J. N. (1997) Biochemistry 36, 6009-6016[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Thoma, R., Hennig, M., Sterner, R., and Kirschner, K. (2000) Struct. Fold. Des. 8, 265-276[Medline] [Order article via Infotrieve] |
| 14. |
Knöchel, T.,
Pappenberger, A.,
Jansonius, J. N.,
and Kirschner, K.
(2002)
J. Biol. Chem.
277,
8626-8634 |
| 15. | Sterner, R., Merz, A., Thoma, R., and Kirschner, K. (2001) Methods Enzymol. 331, 270-280[Medline] [Order article via Infotrieve] |
| 16. | Dahm, A. (1997) Molecular Evolution of Thermostable TIM-Barrel Enzymes of Tryptophan Biosynthesis.Ph.D. thesis , University of Basel, Switzerland |
| 17. | Miles, E. W. (1991) Adv. Enzymol. Rel. Areas. Mol. Biol. 64, 93-173[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Hyde, C. C.,
Ahmed, S. A.,
Padlan, E. A.,
Miles, E. W.,
and Davies, D. R.
(1988)
J. Biol. Chem.
263,
17857-17871 |
| 19. |
Yamagata, Y.,
Ogasahara, K.,
Hioki, Y.,
Lee, S. J.,
Nakagawa, A.,
Nakamura, H.,
Ishida, M.,
Kuramitsu, S.,
and Yutani, K. J.
(2001)
J. Biol. Chem.
276,
11062-11071 |
| 20. | Wierenga, R. K. (2001) FEBS Lett. 492, 193-198[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Höcker, B., Jürgens, C., Wilmanns, M., and Sterner, R. (2001) Curr. Opin. Biotechnol. 12, 376-381[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Miles, E. W.,
Rhee, S.,
and Davies, D. R.
(1999)
J. Biol. Chem.
274,
12193-12196 |
| 23. | Huang, X., Holden, H. M., and Raushel, F. M. (2001) Annu. Rev. Biochem. 70, 149-180[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Pan, P., Woehl, E., and Dunn, M. F. (1997) Trends Biochem. Sci. 22, 22-27[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Fan, Y. X., McPhie, P., and Miles, E. W. (2000) Biochemistry 39, 4692-4703[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Rhee, S., Parris, K. D., Hyde, C. C., Ahmed, S. A., Miles, E. W., and Davies, D. R. (1997) Biochemistry 36, 7664-7680[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Rhee, S., Miles, E. W., Mozzarelli, A., and Davies, D. R. (1998) Biochemistry 37, 10653-10659[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Rhee, S.,
Miles, E. W.,
and Davies, D. R.
(1998)
J. Biol. Chem.
273,
8553-8555 |
| 29. | Schneider, T. R., Gerhardt, E., Lee, M., Liang, P. H., Anderson, K. S., and Schlichting, I. (1998) Biochemistry 37, 5394-5406[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Weyand, M., and Schlichting, I. (1999) Biochemistry 38, 16469-16480[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Nelson, K. E., Clayton, R. A., Gill, S. R., Gwinn, M. L., Dodson, R. J., Haft, D. H., Hickey, E. K., Peterson, J. D., Nelson, W. C., Ketchum, K. A., McDonald, L., Utterback, T. R., Malek, J. A., Linher, K. D., Garrett, M. M., Stewart, A. M., Cotton, M. D., Pratt, M. S., Phillips, C. A., Richardson, D., Heidelberg, J., Sutton, G. G., Fleischmann, R. D., Eisen, J. A., White, O., Salzberg, S. L., Smith, H. O., and Fraser, C. M. (1999) Nature 399, 323-329[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Beismann-Driemeyer, S.,
and Sterner, R.
(2001)
J. Biol. Chem.
276,
20387-20396 |
| 33. | Kopetzki, E., Schumacher, G., and Buckel, P. (1989) Mol. Gen. Genet. 216, 149-155[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Pappenberger, G., Schurig, H., and Jaenicke, R. (1997) J. Mol. Biol. 274, 676-683[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., and Gray, T. (1995) Protein Sci. 4, 2411-2423[Abstract] |
| 37. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Creighton, T. E. (1970) Eur. J. Biochem. 13, 1-10[Medline] [Order article via Infotrieve] |
| 39. | Eisenthal, R., and Cornish-Bowden, A. (1974) Biochem. J. 139, 715-720[Medline] [Order article via Infotrieve] |
| 40. | Faeder, E. J., and Hammes, G. G. (1970) Biochemistry 9, 4043-4049[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Hommel, U., Eberhard, M., and Kirschner, K. (1995) Biochemistry 34, 5429-5439[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Brzovic, P. S., Ngo, K., and Dunn, M. F. (1992) Biochemistry 31, 3831-3839[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Lane, A. N., and Kirschner, K. (1991) Biochemistry 30, 479-484[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89[Medline] [Order article via Infotrieve] |
| 45. | Tang, X. F., Ezaki, S., Atomi, H., and Imanaka, T. (2000) Eur. J. Biochem. 267, 6369-6377[Medline] [Order article via Infotrieve] |
| 46. |
Jaenicke, R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2962-2964 |
| 47. | Jaenicke, R. (1991) Eur. J. Biochem. 202, 715-728[Medline] [Order article via Infotrieve] |
| 48. | Somero, G. N. (1995) Annu. Rev. Physiol. 57, 43-68[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Frey, M.,
Stettner, C.,
Pare, P. W.,
Schmelz, E. A.,
Tumlinson, J. H.,
and Gierl, A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14801-14806 |
| 50. |
Wang, D.,
Ding, X.,
and Rather, P. N.
(2001)
J. Bacteriol.
183,
4210-4216 |
| 51. |
Anderson, K. S.,
Miles, E. W.,
and Johnson, K. A.
(1991)
J. Biol. Chem.
266,
8020-8033 |
| 52. | Leja, C. A., Woehl, E. U., and Dunn, M. F. (1995) Biochemistry 16, 6552-6561 |
| 53. | Stetter, K. O. (1996) FEMS Microbiol. Rev. 18, 149-158[CrossRef] |
| 54. | Weischet, W. O., and Kirschner, K. (1976) Eur. J. Biochem. 65, 375-385[Medline] [Order article via Infotrieve] |
| 55. | Kirschner, K., Lane, A. N., and Strasser, A. W. (1991) Biochemistry 30, 472-478[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Lane, A. N., and Kirschner, K. (1983) Eur. J. Biochem. 129, 561-570[Medline] [Order article via Infotrieve] |
| 57. | Lane, A. N., and Kirschner, K. (1983) Eur. J. Biochem. 129, 571-582[Medline] [Order article via Infotrieve] |